San Francisco, CA, United States of America

Jessica Richman

This inventor holds 95 USPTO granted patents and 34 published patent applications, plus 8 CIPO patents and 9 EPO patents, primarily in Microbiome Diagnostics (CPC class G06F19-3418). Top assignees: Ubiome, Inc., Psomagen, Inc., Macrogen Corp.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jessica Richman. Retrieved from https://idiyas.com/inventor/jessica-richman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 95 (Patent Applications = 34)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 48)

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 370(Granted Patents)

Forward Citations (Not Self Cited) = 166(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Fancisco, CA (US) (2019)
San Francisco, CA (US) (2017 - 2024)

Company Filing History:

4. 1 out of 834,659

Other

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Microbiome

Diagnostics

Therapeutics

Allergy Treatments

CRISPR

Nucleic Acid Sequencing

Bacterial Vaginosis

Pharmacogenomics

Electrode Systems

Trimethylamine

Reproductive Health

Mental Health

95 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576123 - Epitope-Based Approach for Allergy Treatments and Inhibitors for Crohn's Disease (2026-03-17),

2. 12461096 - Manipulation of sample droplets with an electrode system (2025-11-04),

3. 12060599 - Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis (2024-08-13),

4. 11987841 - Single molecule sequencing and unique molecular identifiers to characterize nucleic acid sequences (2024-05-21),

5. 11931400 - Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof (2024-03-19),

6. 11783914 - Method and system for panel characterizations (2023-10-10),

7. 11773455 - Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage (2023-10-03),

8. 11634703 - Method and system for high-throughput particle handling by use of magnetic fields and device (2023-04-25),

9. 11621055 - Microorganism-related significance index metrics (2023-04-04),

10. 11572555 - Method and system for CRISPR-based library preparation and sequencing (2023-02-07),

11. 11424006 - Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide (2022-08-23),

12. 11001900 - Method and system for characterization for female reproductive system-related conditions associated with microorganisms (2021-05-11),

13. 10955411 - Manipulation of sample droplets with an electrode system (2021-03-23),

14. 10902938 - Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions (2021-01-26),

15. 10803992 - Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions (2020-10-13),

Title: **Jessica Richman: Pioneer in Microbiome-Driven Diagnostics**

Introduction

Jessica Richman, located in San Francisco, CA, is a distinguished inventor holding an impressive portfolio of 93 patents. Her work primarily focuses on pioneering innovative solutions in microbiome-derived diagnostics and therapeutics, significantly impacting the medical field.

Latest Patents

Among her latest patents is a groundbreaking method and system for microbiome-derived diagnostics and therapeutics specifically targeting bacterial vaginosis. This invention provides methods, compositions, and systems for detecting bacterial vaginosis by characterizing an individual's microbiome. It includes monitoring effects and promoting therapies tailored for bacterial vaginosis issues. Furthermore, it allows for generating and comparing microbiome composition and functional diversity datasets, along with creating characterization and therapy models for bacterial vaginosis. Another notable patent revolves around single molecule sequencing and unique molecular identifiers, enhancing the process of single molecule sequencing using UMI-based molecules linked to target nucleic acid sequences.

Career Highlights

Throughout her career, Richman has made significant contributions by working with innovative companies such as uBiome, Inc. and Psomagen, Inc. Her roles in these organizations allowed her to advance her research and apply her inventions in practical settings.

Collaborations

Jessica has collaborated with notable individuals in her field, including Zachary Apte and Daniel Almonacid. These partnerships highlight her ability to work with other talented professionals to drive forward important advancements in microbiome research.

Conclusion

Jessica Richman's dedication to innovation in microbiome diagnostics and therapeutics stands out in the medical and scientific communities. Her extensive patent portfolio and collaborative efforts reflect a commitment to improving health outcomes through groundbreaking technology. The future of microbiome research looks promising with inventors like Richman at the forefront.

Profile summary based on public USPTO records.